Targeted neoadjuvant therapy in the HER-2-positive breast cancer patients: a systematic review and meta-analysis
Sign Up to like & getrecommendations! Published in 2019 at "OncoTargets and therapy"
DOI: 10.2147/ott.s183304
Abstract: Aim To evaluate efficacy and safety of lapatinib or trastuzumab alone or both plus chemotherapy for the treatment of breast cancer patients with positive HER-2 expression. Methods Cochrane Central Register of Controlled Trials, PubMed, MEDLINE,… read more here.
Keywords: chemotherapy; chemotherapy plus; plus lapatinib; breast cancer ... See more keywords